Attività
Numero di dipendenti: 4
Vendite per attività
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Central Nervous System Drug
85,1
%
| 0 | 42,1 % | 1 | 85,1 % | +17,39% |
Services
14,9
%
| 1 | 57,9 % | 0 | 14,9 % | -85,11% |
Vendite per regione
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
53,0
%
| 1 | 61,0 % | 0 | 53,0 % | -49,59% |
International
47,0
%
| 0 | 39,0 % | 0 | 47,0 % | -30,09% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Andrew LaFrence
CEO | Chief Executive Officer | 61 | 01/08/19 |
Jay Roberts
BRD | Director/Board Member | - | 01/04/18 |
Yung Ping Yeh
BRD | Director/Board Member | 48 | 01/03/21 |
John Roberts
BRD | Director/Board Member | 65 | 11/07/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Geoffrey Harris
BRD | Director/Board Member | 61 | 01/01/14 |
Joanna Horobin
BRD | Director/Board Member | 69 | 01/01/21 |
R. Fletcher
CHM | Chairman | 78 | 30/03/21 |
John Roberts
BRD | Director/Board Member | 65 | 11/07/16 |
Howard McLeod
BRD | Director/Board Member | 57 | 01/01/14 |
Yung Ping Yeh
BRD | Director/Board Member | 48 | 01/03/21 |
Paul Hansen
BRD | Director/Board Member | 61 | 01/01/21 |
Jay Roberts
BRD | Director/Board Member | - | 01/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 328 752 | 5 140 411 ( 81,22 %) | 0 | 81,22 % |
Coordinate società
Vyant Bio, Inc.
2 Executive Campus 2370 State Route 70 West
08002, Cherry Hill
+
http://www.vyantbio.comVendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+173,89% | 6,55 Mrd | |
+5,57% | 1,05 Mrd | |
+2,29% | 983 Mln | |
+41,91% | 872 Mln | |
+20,36% | 786 Mln | |
+1,72% | 664 Mln | |
+40,25% | 639 Mln | |
-.--% | 600 Mln | |
-2,15% | 593 Mln |